Log in to save to my catalogue

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging...

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11464113

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging‐related diseases

About this item

Full title

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging‐related diseases

Publisher

England: John Wiley & Sons, Inc

Journal title

Aging cell, 2024-10, Vol.23 (10), p.e14317-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

CD4+T cells play a notable role in immune protection at different stages of life. During aging, the interaction between the body's internal and external environment and CD4+T cells results in a series of changes in the CD4+T cells pool making it involved in immunosenescence. Many studies have extensively examined the subsets and functionality of CD...

Alternative Titles

Full title

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging‐related diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11464113

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11464113

Other Identifiers

ISSN

1474-9718,1474-9726

E-ISSN

1474-9726

DOI

10.1111/acel.14317

How to access this item